VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 52 filers reported holding VERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $602,349 | +81.0% | 43,935 | +111.9% | 0.00% | – |
| Q2 2023 | $332,765 | +380.0% | 20,733 | +132.1% | 0.00% | – |
| Q1 2023 | $69,320 | +299.4% | 8,933 | +895.9% | 0.00% | – |
| Q4 2022 | $17,357 | -84.6% | 897 | -83.1% | 0.00% | – |
| Q3 2022 | $113,000 | +2160.0% | 5,298 | +1241.3% | 0.00% | – |
| Q2 2022 | $5,000 | -89.4% | 395 | -80.3% | 0.00% | – |
| Q1 2022 | $47,000 | +261.5% | 2,009 | +110.1% | 0.00% | – |
| Q2 2021 | $13,000 | – | 956 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $40,289,000 | 12.90% |
| Kynam Capital Management, LP | 1,522,712 | $20,724,000 | 5.29% |
| Sofinnova Investments, Inc. | 3,181,442 | $43,299,000 | 3.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,825 | $281,057,000 | 2.93% |
| Octagon Capital Advisors LP | 575,000 | $7,826,000 | 2.09% |
| Vivo Capital, LLC | 666,666 | $9,073,000 | 0.91% |
| RA Capital Management | 1,578,820 | $21,488,000 | 0.57% |
| Alphabet Inc. | 301,580 | $4,105,000 | 0.22% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $219,000 | 0.11% |
| Polar Asset Management Partners Inc. | 294,300 | $4,005,000 | 0.05% |